Microfluidic Manufacture of Solid Lipid Nanoparticles: A Case Study on Tristearin-Based Systems (original) (raw)
Related papers
Scalable Manufacturing Processes for Solid Lipid Nanoparticles
Pharmaceutical Nanotechnology
Background: Solid lipid nanoparticles offer a range of advantages as delivery systems but they are limited by effective manufacturing processes. Objective: In this study, we outline a high-throughput and scalable manufacturing process for solid lipid nanoparticles. Method: The solid lipid nanoparticles were formulated from a combination of tristearin and 1,2-Distearoyl-phosphatidylethanolamine-methyl-polyethyleneglycol conjugate-2000 and manufactured using the M-110P Microfluidizer processor (Microfluidics Inc, Westwood, Massachusetts, US). Results: The manufacturing process was optimized in terms of the number of process cycles (1 to 5) and operating pressure (20,000 to 30,000 psi). The solid lipid nanoparticles were purified using tangential flow filtration and they were characterized in terms of their size, PDI, Z-potential and protein loading. At-line particle size monitoring was also incorporated within the process. Our results demonstrate that solid lipid nanoparticles can be ...
Pharmaceutics
Microfluidics is an emerging technology that can be employed as a powerful tool for designing lipid nano-microsized structures for biological applications. Those lipid structures can be used as carrying vehicles for a wide range of drugs and genetic materials. Microfluidic technology also allows the design of sustainable processes with less financial demand, while it can be scaled up using parallelization to increase production. From this perspective, this article reviews the recent advances in the synthesis of lipid-based nanostructures through microfluidics (liposomes, lipoplexes, lipid nanoparticles, core-shell nanoparticles, and biomimetic nanovesicles). Besides that, this review describes the recent microfluidic approaches to produce lipid micro-sized structures as giant unilamellar vesicles. New strategies are also described for the controlled release of the lipid payloads using microgels and droplet-based microfluidics. To address the importance of microfluidics for lipid-nan...
Microfluidic approach for production of lipid nanoparticles-based nano medicine
2015
This paper described a simple preparation method for small-size and monodispersed lipid nanoparticles (LNPs) by using microfluidic devices. The fundamental role and importance of chaotic micromixer in the microfluidic device was demonstrated. The suitable cycle number of chaotic micromixer was confirmed for precise controlling LNPs size with narrow distribution under the any flow rate conditions. In addition, LNPs containing siRNA was synthesized for evaluation of penetration efficiency via in vivo experiment. The PEGylated LNPs containing siRNA with a diameter of 30 nm could penetrate to the mouse parenchymal liver cells rather than the LNPs with a diameter of 50 nm.
Pharmaceutics, 2019
The aim of this work was to assess the impact of solvent selection on the microfluidic production of liposomes. To achieve this, liposomes were manufactured using small-scale and bench-scale microfluidics systems using three aqueous miscible solvents (methanol, ethanol or isopropanol, alone or in combination). Liposomes composed of different lipid compositions were manufactured using these different solvents and characterised to investigate the influence of solvents on liposome attributes. Our studies demonstrate that solvent selection is a key consideration during the microfluidics manufacturing process, not only when considering lipid solubility but also with regard to the resultant liposome critical quality attributes. In general, reducing the polarity of the solvent (from methanol to isopropanol) increased the liposome particle size without impacting liposome short-term stability or release characteristics. Furthermore, solvent combinations such as methanol/isopropanol mixtures ...
Solid Lipid Microparticles (SLMS): An Effective Lipid Based Technology for Controlled Drug Delivery
The idea that led to this review was conceived after some investigations we carried out showed that solid lipid microparticles (SLMs) have very good prospects as a good and an effective alternative to the traditional colloidal carrier systems like liposomes, emulsions and polymeric microparticles, for the encapsulation, targeting and controlled delivery of drugs and other actives. This was corroborated by reports from several researchers working in other laboratories. Hence, the review aims at showing that SLMs are at the forefront of the rapidly developing field of lipid-based drug delivery and technology with several potential applications in drug delivery, clinical medicine and research. This review presents the various formulation techniques applied as well as relevant issues such as factors considered in drug encapsulation and loading capacity of SLMs, and methods of characterization of SLMs are treated. The important routes of administration of SLMs and examples of candidate d...
Technological strategies for the preparation of lipid nanoparticles: an updated review
Pharmacia
The concept of improving drug biopharmaceutical properties by proper selection of delivery system should begin with a rational choice of relevant dosage form, followed by the precise assessment of physicochemical compatibility between the drug delivery system (DDS) and the active pharmaceutical ingredient (API). Afterwards, according to laboratory availabilities, an efficient production method should be selected and, if possible, to take into account the opportunity for lab-upscale and prevailed industry research needs. Amid the vast diversity of nanostructured drug delivery carriers, lipid nanoparticles (LNs) stand out with their undeniable advantages like exceptive biocompatibility and multiplicity, and their importance as “green” derivatives for biochemical processes. Their distinctive structural properties also allow adequate protection of loaded APIs against chemical degradation in an aggressive biological environment and provide excellent resiliency in modifying drug release p...
A Comprehensive Review on Solid Lipid Nanoparticles
IJPPR, 2022
Polymeric nanoparticles can be used as an alternative compared to other classic colloidal carriers like liposomes, and emulsions due to their benefits such as controlled delivery of drugs, focused drug delivery, and enhanced stability, solid lipid nanoparticles were created in the early 1990s. This page provides a overview of the possible benefits and drawbacks of solid lipid nanoparticles, excipients, and all of the many techniques used to make them, including the membrane contractor approach. aspects of the stability of SLN and the impact of different excipients (used in the manufacturing of SLN) on stability, as well as other secondary stages involved in their stabilization, such as freeze drying, spray drying, etc. The issues surrounding SLN manufacture as well as the instrumental methods employed are extensively examined.